Park Chul, Ku Nam Su, Park Dae Won, Park Joo Hyun, Ha Tae Sun, Kim Do Wan, Park So Young, Chang Youjin, Jo Kwang Wook, Baek Moon Seong, Seo Yijun, Shin Tae Gun, Yu Gina, Lee Jongmin, Choi Yong Jun, Jang Ji Young, Jung Yun Tae, Jeong Inseok, Cho Hwa Jin, Woo Ala, Kim Sua, Bae Dae-Hwan, Kang Sung Wook, Park Sun Hyo, Suh Gee Young, Park Sunghoon
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Korea.
Division of Infective Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Acute Crit Care. 2024 Nov;39(4):445-472. doi: 10.4266/acc.2024.00920. Epub 2024 Nov 18.
Despite recent advances and global improvements in sepsis recognition and supportive care, mortality rates remain high, and adherence to sepsis bundle components in Korea is low. To address this, the Korean Sepsis Alliance, affiliated with the Korean Society of Critical Care Medicine, developed the first sepsis treatment guidelines for Korea based on a comprehensive systematic review and meta-analysis.
A de novo method was used to develop the guidelines. Methodologies included determining key questions, conducting a literature search and selection, assessing the risk of bias, synthesizing evidence, and developing recommendations. The certainty of evidence and the strength of recommendations were determined using the Grading of Recommendations, Assessment, Development, and Evaluations approach. Draft recommendations underwent internal and external review processes and public hearings. The development of these guidelines was supported by a research grant from the Korean Disease Control and Prevention Agency.
In these guidelines, we focused on early treatments for adult patients with sepsis and septic shock. Through the guideline development process, 12 key questions and their respective recommendations were formulated. These include lactate measurement, fluid therapies, target blood pressure, antibiotic administration, use of vasopressors and dobutamine, extracorporeal membrane oxygenation, and echocardiography.
These guidelines aim to support medical professionals in making appropriate decisions about treating adult sepsis and septic shock. We hope these guidelines will increase awareness of sepsis and reduce its mortality rate.
尽管近期在脓毒症识别和支持治疗方面取得了进展,全球范围内的治疗情况也有所改善,但死亡率仍然很高,而且韩国对脓毒症集束化治疗措施的依从性较低。为解决这一问题,隶属于韩国重症医学会的韩国脓毒症联盟,基于全面的系统评价和荟萃分析,制定了韩国首个脓毒症治疗指南。
采用全新方法制定本指南。方法包括确定关键问题、进行文献检索与筛选、评估偏倚风险、综合证据以及制定建议。使用推荐分级的评估、制定与评价方法确定证据的确定性和建议的强度。推荐草案经过了内部和外部审查流程以及公开听证会。这些指南的制定得到了韩国疾病控制与预防机构的一项研究资助。
在这些指南中,我们重点关注成年脓毒症和脓毒性休克患者的早期治疗。通过指南制定过程,制定了12个关键问题及其各自的建议。这些包括乳酸测量、液体治疗、目标血压、抗生素给药、血管升压药和多巴酚丁胺的使用、体外膜肺氧合以及超声心动图检查。
这些指南旨在支持医学专业人员对成年脓毒症和脓毒性休克的治疗做出恰当决策。我们希望这些指南将提高对脓毒症的认识并降低其死亡率。